Prognostic significance of E-cadherin and N-cadherin expression in Gliomas

[1]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[2]  Yasuo Iwadate,et al.  Epithelial-mesenchymal transition in glioblastoma progression , 2016, Oncology letters.

[3]  S. Kwon,et al.  Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance , 2015, PloS one.

[4]  Shin Jung,et al.  KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers , 2014, Oncotarget.

[5]  G. Nikkhah,et al.  Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. , 2013, Cancer letters.

[6]  G. Nikkhah,et al.  Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. , 2012, Cancer letters.

[7]  H. Ohgaki,et al.  Transcriptional Factors for Epithelial–Mesenchymal Transition Are Associated with Mesenchymal Differentiation in Gliosarcoma , 2012, Brain pathology.

[8]  Hao Wang,et al.  ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in Glioma , 2012, PloS one.

[9]  T. Brabletz.  To differentiate or not — routes towards metastasis , 2012, Nature Reviews Cancer.

[10]  A. Puisieux,et al.  Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia. , 2011, Blood.

[11]  B. Necela,et al.  Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype , 2010, PloS one.

[12]  N. Johnson,et al.  Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions. , 2010, International journal of oncology.

[13]  Richard Beyer,et al.  TWIST1 promotes invasion through mesenchymal change in human glioblastoma , 2010, Molecular Cancer.

[14]  Mark D. Johnson,et al.  SNAI2/Slug promotes growth and invasion in human gliomas , 2010, BMC Cancer.

[15]  D. Radisky,et al.  Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[16]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[17]  E. Neilson,et al.  Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.

[18]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[19]  Charles Duyckaerts,et al.  The 2007 WHO classification of tumors of the central nervous system – what has changed? , 2008, Current opinion in neurology.

[20]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[21]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[22]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[23]  R. Holcombe,et al.  Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos‐2 cells , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[25]  Thomas Kirchner,et al.  Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.

[26]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[27]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[28]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[29]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[30]  R. Nagle,et al.  N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells. , 1999, The American journal of pathology.

[31]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[32]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.

[33]  J. Sneep,et al.  With a summary , 1945 .